{"nct_id":"NCT04136145","title":"Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy Subjects","status":"COMPLETED","status_verified_date":"2020-11","start_date":"2019-10-28","start_date_type":"ACTUAL","primary_completion_date":"2020-01-14","primary_completion_date_type":"ACTUAL","completion_date":"2020-01-14","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}